FDA Lays Out Drug Naming Standards For Advertisements

Law360, New York (November 18, 2013, 3:13 PM EST) -- The U.S. Food and Drug Administration on Monday described in granular detail how advertisements for prescription drugs must list a product's active ingredient in print and broadcast settings, a policy intended to ensure that different brand names don't cause confusion.

In its draft guidance, the FDA covered numerous hypothetical situations across a range of media, from brochures and television ads to radio spots and emails, and also described situations in which it wouldn't punish drugmakers even if their promotional materials technically were noncompliant.

In addition to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.